CELLINK Q5 2020 Results and MatTek Acquisition

1 Long-term financial targets 2019-2022 CELLINK "LIFE SCIENCES 94 Organic growth CELLINK's objective is to achieve an annual organic sales growth of >35%, supplemented by strategic acquisitions. EBITDA margin CELLINK's objective is to have a positive EBITDA margin. Capital structure CELLINK aims to maintain a ratio of Net Debt to EBITDA of 3.0x, and may temporarily exceed this level (e.g., as a result of acquisitions). CELLINK 2021, All rights reserved.

View entire presentation